Sodium-glucose cotransporter 2 inhibitors and nephrolithiasis risk in patients with type 2 diabetes
Paik JM, Tesfaye H, Curhan GC, et al.
JAMA Intern Med. Pub. online 29 Jan 2024.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Impact of socioeconomic status on chronic control and complications of type 1 diabetes mellitus in users of glucose flash systems: A follow-up study
Sebastian-Valles F, Martínez-Alfonso J, Arranz Martin JA, et al.
BMC Med. 2024;22(1):37.
Leggi
Continuous Glucose Monitor Metrics are associated with ED visits and hospitalizations for hypoglycemia and hyperglycemia but have low predictive value
Gilliam LK, Parker MM, Moffet HH, et al.
Diabetes Technol Ther. Pub. online 26 Jan 2024.
Leggi
Does emotional distress predict worse glycemic control over time? Results from the glycemia reduction approaches in diabetes: A comparative effectiveness study (GRADE)
Cherrington AL, Bebu I, Krause-Steinrauf H, et al.
Diabetes Care. 2024: dc230642.
Leggi
Adaptive infusion of a glucagon‐like peptide‐1/glucagon receptor co‐agonist G3215, in adults with overweight or obesity: Results from a phase 1 randomized clinical trial
Hope DCD, Ansari S, Choudhury S, et al.
Diabetes Obes Metab. Pub. online 16 Jan 2024.
Leggi
The risk prediction of intergenerational transmission of overweight and obesity between mothers and infants during pregnancy
Wei X, Hu J, Wen D
BMC Pregnancy Childbirth. Pub. online 23 Jan 2024.
Leggi
Mortality in Glycemia Reduction Approaches in Diabetes: A comparative effectiveness study (GRADE)
Banerji MA, Buse JB, Younes N, et al.
Diabetes Care. dc231356.
Leggi
Risk factor control and incident cardiovascular disease in patients with diabetes: Sex‐specific relations
Wang X, Ma H, Li X, et al.
Diabetes Obes Metab. Pub. online 16 Jan 2024.
Leggi
Pre‐exercise protein intake is associated with reduced time in hypoglycaemia among adolescents with type 1 diabetes
Muntis FR, Crandell JL, Evenson KR, et al.
Diabetes Obes Metab. Pub. online 15 Jan 2024.
Leggi
Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32‐week randomized trial
Vernstrøm L, Gullaksen S, Sørensen SS, et al.
Diabetes Obes Metab. Pub. online 19 Jan 2024.
Leggi